The potential of the nutraceutical berberine in the treatment of hepatocellular carcinoma and other liver diseases such as NAFLD and NASH-Reference-Cited by-同舟云学术

The potential of the nutraceutical berberine in the treatment of hepatocellular carcinoma and other liver diseases such as NAFLD and NASH

Published:2024-05 Issue: Volume:92 Page:101032
ISSN:2212-4926
Container-title:Advances in Biological Regulation
language:en
Short-container-title:Advances in Biological Regulation

Author:

Cervello Melchiorre,Augello Giuseppa,Cocco Lucio,Ratti Stefano,Follo Matilde Y.,Martelli Alberto M.,Cusimano Antonella,Montalto Giuseppe,McCubrey James A.^ORCID

Publisher

Elsevier BV

Reference134 articles.

1. Coptis chinensis inhibits hepatocellular carcinoma cell growth through nonsteroidal anti-inflammatory drug-activated gene activation;Auyeung;Int. J. Mol. Med.,2009

2. 9-O-benzoyl-substituted berberine exerts a triglyceride-lowering effect through AMPK signaling pathway in human hepatoma HepG2 cells;Cao;Environ. Toxicol. Pharmacol.,2018

3. Coptisine from Rhizoma coptidis exerts an anti-cancer effect on hepatocellular carcinoma by up-regulating miR-122;Chai;Biomed. Pharmacother. = Biomedecine & Pharmacotherapie.,2018

4. Lipid profiling of the therapeutic effects of berberine in patients with nonalcoholic fatty liver disease. Randomized Controlled Trial;Chang;J. Transl. Med.,2016

5. Comparing the influences of metformin and berberine on the intestinal microbiota of rats with nonalcoholic steatohepatitis;Chen;In Vivo,2023

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Natural Alkaloids in Cancer Therapy: Berberine, Sanguinarine and Chelerythrine against Colorectal and Gastric Cancer;International Journal of Molecular Sciences;2024-07-31